Frank Cheng

Led multiple digital health companies during last twenty years. Held executive positions with publicly traded companies (GE, Roche, Hillrom, Stereotaxis) and led two venture-backed companies as CEO. Most recently President & CCO of diagnostic company with autonomous AI technology that was FDA-cleared, Medicare-reimbursed, supported by a new Category 1 CPT code, and adopted around the world.